
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5219307
[patent_doc_number] => 20070160618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR'
[patent_app_type] => utility
[patent_app_number] => 11/535254
[patent_app_country] => US
[patent_app_date] => 2006-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32046
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160618.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535254
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535254 | CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR | Sep 25, 2006 | Abandoned |
Array
(
[id] => 4657522
[patent_doc_number] => 20080026383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Chronic lymphocytic leukaemia'
[patent_app_type] => utility
[patent_app_number] => 11/525517
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11177
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11525517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/525517 | Chronic lymphocytic leukaemia | Sep 21, 2006 | Issued |
Array
(
[id] => 334291
[patent_doc_number] => 07507703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-24
[patent_title] => 'Method of cancer screening; method of cancer treatment; and method of diabetes treatment'
[patent_app_type] => utility
[patent_app_number] => 11/533805
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2554
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/507/07507703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11533805
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/533805 | Method of cancer screening; method of cancer treatment; and method of diabetes treatment | Sep 20, 2006 | Issued |
Array
(
[id] => 5135954
[patent_doc_number] => 20070077583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance'
[patent_app_type] => utility
[patent_app_number] => 11/524780
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 38968
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077583.pdf
[firstpage_image] =>[orig_patent_app_number] => 11524780
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/524780 | Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance | Sep 20, 2006 | Abandoned |
Array
(
[id] => 4682275
[patent_doc_number] => 20080248501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Methods of Diagnosing Ovarian Cancer and Kits Therefor'
[patent_app_type] => utility
[patent_app_number] => 12/066564
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 9300
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248501.pdf
[firstpage_image] =>[orig_patent_app_number] => 12066564
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066564 | Methods of diagnosing ovarian cancer and kits therefor | Sep 14, 2006 | Issued |
Array
(
[id] => 5095514
[patent_doc_number] => 20070117123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'SALIVARY PROTEIN AND RNA FOR BREAST CANCER DETECTION'
[patent_app_type] => utility
[patent_app_number] => 11/531967
[patent_app_country] => US
[patent_app_date] => 2006-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10227
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11531967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/531967 | SALIVARY PROTEIN AND RNA FOR BREAST CANCER DETECTION | Sep 13, 2006 | Abandoned |
Array
(
[id] => 63360
[patent_doc_number] => 07759060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'Molecular method for diagnosis of prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 11/519892
[patent_app_country] => US
[patent_app_date] => 2006-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3800
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/759/07759060.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519892
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519892 | Molecular method for diagnosis of prostate cancer | Sep 12, 2006 | Issued |
Array
(
[id] => 4860256
[patent_doc_number] => 20080269106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Methods and Compositions for Diagnosis and Treatment of Disorders Involving Macrophages'
[patent_app_type] => utility
[patent_app_number] => 12/066428
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27087
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269106.pdf
[firstpage_image] =>[orig_patent_app_number] => 12066428
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066428 | Methods and Compositions for Diagnosis and Treatment of Disorders Involving Macrophages | Sep 11, 2006 | Abandoned |
Array
(
[id] => 5520882
[patent_doc_number] => 20090028863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE'
[patent_app_type] => utility
[patent_app_number] => 12/066615
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12259
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20090028863.pdf
[firstpage_image] =>[orig_patent_app_number] => 12066615
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066615 | MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE | Sep 11, 2006 | Abandoned |
Array
(
[id] => 5159799
[patent_doc_number] => 20070172843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'MEK interacting protein 1 as diagnostic and therapeutic target for breast cancer treatment and prevention'
[patent_app_type] => utility
[patent_app_number] => 11/518636
[patent_app_country] => US
[patent_app_date] => 2006-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5177
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172843.pdf
[firstpage_image] =>[orig_patent_app_number] => 11518636
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/518636 | MEK interacting protein 1 as diagnostic and therapeutic target for breast cancer treatment and prevention | Sep 10, 2006 | Abandoned |
Array
(
[id] => 4463782
[patent_doc_number] => 07935491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-03
[patent_title] => 'Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/518610
[patent_app_country] => US
[patent_app_date] => 2006-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 51
[patent_no_of_words] => 127035
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935491.pdf
[firstpage_image] =>[orig_patent_app_number] => 11518610
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/518610 | Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer | Sep 7, 2006 | Issued |
Array
(
[id] => 6487750
[patent_doc_number] => 20100009347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Kit and method for detecting urothelial cancer'
[patent_app_type] => utility
[patent_app_number] => 11/991184
[patent_app_country] => US
[patent_app_date] => 2006-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13275
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009347.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991184
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991184 | Kit and method for detecting urothelial cancer | Aug 31, 2006 | Issued |
Array
(
[id] => 5135949
[patent_doc_number] => 20070077578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Diagnosis of (a risk of ) disease and monitoring of therapy'
[patent_app_type] => utility
[patent_app_number] => 11/514345
[patent_app_country] => US
[patent_app_date] => 2006-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10579
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077578.pdf
[firstpage_image] =>[orig_patent_app_number] => 11514345
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/514345 | Diagnosis of (a risk of ) disease and monitoring of therapy | Aug 30, 2006 | Abandoned |
Array
(
[id] => 5040618
[patent_doc_number] => 20070092900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer'
[patent_app_type] => utility
[patent_app_number] => 11/515368
[patent_app_country] => US
[patent_app_date] => 2006-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24124
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092900.pdf
[firstpage_image] =>[orig_patent_app_number] => 11515368
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/515368 | Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer | Aug 30, 2006 | Abandoned |
Array
(
[id] => 6585033
[patent_doc_number] => 20100047840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Polypeptide markers for the diagnosis of bladder cancer'
[patent_app_type] => utility
[patent_app_number] => 11/991035
[patent_app_country] => US
[patent_app_date] => 2006-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17920
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047840.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991035
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991035 | Polypeptide markers for the diagnosis of bladder cancer | Aug 27, 2006 | Abandoned |
Array
(
[id] => 42375
[patent_doc_number] => 07781174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Proliferation markers in clinical practice and their use for cancer prognosis or diagnosis'
[patent_app_type] => utility
[patent_app_number] => 11/510612
[patent_app_country] => US
[patent_app_date] => 2006-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 11306
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781174.pdf
[firstpage_image] =>[orig_patent_app_number] => 11510612
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/510612 | Proliferation markers in clinical practice and their use for cancer prognosis or diagnosis | Aug 27, 2006 | Issued |
Array
(
[id] => 5533031
[patent_doc_number] => 20090232819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'METHOD USING SNAIL TRANSCRIPTIONAL REPRESSOR'
[patent_app_type] => utility
[patent_app_number] => 11/991052
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24260
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232819.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991052
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991052 | Method using snail transcriptional repressor | Aug 24, 2006 | Issued |
Array
(
[id] => 5148743
[patent_doc_number] => 20070048803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Immune profiling of lymph nodes associated with cancer'
[patent_app_type] => utility
[patent_app_number] => 11/509976
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17987
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048803.pdf
[firstpage_image] =>[orig_patent_app_number] => 11509976
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/509976 | Immune profiling of lymph nodes associated with cancer | Aug 24, 2006 | Abandoned |
Array
(
[id] => 4663576
[patent_doc_number] => 20080254483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'In Vitro Method for Diagnosing and Monitoring Renal Cell Carcinoma (Rcc) Using Mmp-7 as Humoral Biomarker for Rcc'
[patent_app_type] => utility
[patent_app_number] => 12/064655
[patent_app_country] => US
[patent_app_date] => 2006-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5237
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254483.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064655 | In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC | Aug 20, 2006 | Issued |
Array
(
[id] => 4697788
[patent_doc_number] => 20080219972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/063765
[patent_app_country] => US
[patent_app_date] => 2006-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8846
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20080219972.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063765
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063765 | Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer | Aug 15, 2006 | Abandoned |